|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01789 AK MEDICAL
Nominal 
6.270 +0.460 (+7.917%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 1,482,439 | 10.106% | 1,346,377 | 1,093,862 | 1,052,047 | 761,441 |
| Cost of Sales | (585,044) | 8.707% | (538,184) | (419,376) | (415,612) | (262,252) |
| Gross Profit | 897,395 | 11.037% | 808,193 | 674,486 | 636,435 | 499,189 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (18,360) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 394,979 | 23.500% | 319,822 | 231,117 | 240,290 | 108,559 | |
| Taxation | (55,885) | 21.764% | (45,896) | (49,013) | (35,518) | (15,940) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 339,094 | 23.790% | 273,926 | 182,104 | 204,772 | 92,619 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (21,099) | 10.808% | (19,041) | (19,634) | (20,307) | (9,123) |
| Depreciation & Amortisation | 106,880 | 10.947% | 96,334 | 90,939 | 80,401 | 74,158 |
| Directors' Emoluments | -- | -- | 5,279 | 4,580 | 4,307 | 3,746 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 30.400 | 23.577% | 24.600 | 16.000 | 18.000 | 8.000 |
| DPS (cts) | 10.426 | -- | 6.645 | 4.082 | 5.226 | 2.037 |
| Dividend Payout Ratio (%) | 34.296% | -- | 27.013% | 25.510% | 29.036% | 25.460% |
| Cash flow per share ($) | -- | -- | 0.404 | 0.030 | 0.219 | 0.159 |
| NBV per share ($) | 2.592 | -- | 2.350 | 2.132 | 2.011 | 1.821 |
| Remarks: | Real time quote last updated: 27/03/2026 15:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 339,094 |
| %Change | 23.790% |
| EPS / (LPS) | RMB 0.304 |
| NBV Per Share (¥) | RMB 2.592 |